Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox ...Middle East

STOCKHOLM, Jan. 15, 2024 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that clinical pharmacokinetic (PK) data from the first study with...

Hence then, the article about medivir to present clinical pharmacokinetic data at easl liver cancer summit further supporting the continued development of fostrox was published today ( Monday 15/01/2024 - 11:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox )

Also on site :

• As Backward as His Ideas: Zohran Mamdani Lectures America from the Wrong Side of George Washington’s Desk
• Behind the ‘Supergirl’ Bomb: Competing Cuts, Creative Differences (Exclusive)
• Babar Azam likely to be named as Pakistan Test captain: Reports